MedPath

Optimizing intermittent theta burst stimulation (iTBS) in humans. A randomized controlled cross-over pilot study.

Not Applicable
Conditions
There will be no diseases/health issues examined.
Registration Number
DRKS00031090
Lead Sponsor
Abteilung für Neuroanatomie, Institut für Anatomie und Zellbiologie, Albert-Ludwigs-Universität Freiburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
10
Inclusion Criteria

Normal or corrected-to-normal vision
- Voluntary consent in written form after having received oral and written information about the study
- Right-handed

Exclusion Criteria

- Persons who are unwilling to be informed of potential incidental findings
- Participants who do not provide their consent for sharing their de-identified and pseudonymized data
- Pregnancy, planned pregnancy or breastfeeding
- Brain pathology
- Non-removable metal objects in or at the body (e.g. heart pacemakers)
- Neurological disorder or injury (e.g. epilepsy)
- Psychiatric disorders (e.g. substance use disorder)
- Intake of centrally active medication (e.g. antidepressants)
- Tattoo that is non-compatible with the MRI
- Claustrophobia
- Surgery in the head, neck or chest area
- Acute illness or infection during the preceding 4 weeks

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Motor evoked potential amplitudes measured from a small hand muscle.
Secondary Outcome Measures
NameTimeMethod
Resting motor threshold, active motor threshold, self-reports, physiological biomarkers.
© Copyright 2025. All Rights Reserved by MedPath